SOPHiA GENETICS (SOPH)
(Delayed Data from NSDQ)
$3.69 USD
-0.06 (-1.60%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $3.63 -0.06 (-1.63%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth F Momentum D VGM
Cash flow Statements
Fiscal Year End for SOPHiA GENETICS SA falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -78.50 | -87.59 | -73.51 | -41.23 | -33.63 |
Depreciation/Amortization & Depletion | 8.34 | 5.57 | 3.61 | 2.39 | 1.91 |
Net Change from Assets/Liabilities | 0.87 | -1.27 | 6.07 | 3.97 | -1.87 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 20.71 | 13.19 | 5.89 | 3.14 | 1.91 |
Net Cash From Operating Activities | -48.58 | -70.09 | -57.94 | -31.73 | -31.68 |
Property & Equipment | -1.49 | -4.10 | -2.68 | -0.45 | -1.36 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 17.55 | 52.35 | -50.26 | -21.12 | 0.00 |
Other Investing Activities | -7.73 | -6.28 | -3.99 | -2.75 | -1.68 |
Net Cash from Investing Activities | 8.32 | 41.97 | -56.93 | -24.32 | -3.03 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.23 | 0.75 | 216.19 | 108.72 | 1.76 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | -3.17 | -0.69 | -1.97 |
Increase (Decrease) Short-Term Debt | -3.04 | -2.32 | -0.92 | -0.98 | -0.82 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 25.67 | 0.00 | 0.00 |
Net Cash from Financing Activities | -2.82 | -1.57 | 237.77 | 107.05 | -1.02 |
Effect of Exchange Rate Changes | 5.02 | -1.97 | -4.56 | 5.56 | -0.10 |
Net Change In Cash & Equivalents | -38.05 | -31.66 | 118.34 | 56.56 | -35.84 |
Cash at Beginning of Period | 161.31 | 192.96 | 74.63 | 18.07 | 53.91 |
Cash at End of Period | 123.25 | 161.31 | 192.96 | 74.63 | 18.07 |
Diluted Net EPS | -1.22 | -1.36 | -1.33 | -0.93 | NA |
Fiscal Year End for SOPHiA GENETICS SA falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -28.42 | -13.39 | -78.50 | -54.44 | -40.92 |
Depreciation/Amortization & Depletion | 4.10 | 2.06 | 8.34 | 6.36 | 4.15 |
Net Change from Assets/Liabilities | -2.80 | -1.70 | 0.87 | -4.55 | 0.91 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 3.28 | -0.81 | 20.71 | 15.36 | 10.74 |
Net Cash From Operating Activities | -23.84 | -13.84 | -48.58 | -37.28 | -25.11 |
Property & Equipment | -0.11 | -0.10 | -1.49 | -1.37 | -1.25 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 17.55 | 17.55 | 17.55 |
Other Investing Activities | -3.80 | -1.86 | -7.73 | -5.61 | -3.63 |
Net Cash from Investing Activities | -3.92 | -1.96 | 8.32 | 10.57 | 12.67 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.30 | 0.19 | 0.23 | 0.21 | 0.21 |
Issuance (Repayment) of Debt | 13.93 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | -1.48 | -0.74 | -3.04 | -2.52 | -1.76 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | -0.05 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 12.75 | -0.60 | -2.82 | -2.31 | -1.55 |
Effect of Exchange Rate Changes | -2.85 | -3.12 | 5.02 | 0.49 | 1.24 |
Net Change In Cash & Equivalents | -17.86 | -19.52 | -38.05 | -28.54 | -12.75 |
Cash at Beginning of Period | 123.25 | 123.25 | 161.31 | 161.31 | 161.31 |
Cash at End of Period | 105.40 | 103.74 | 123.25 | 132.77 | 148.55 |
Diluted Net EPS | -0.23 | -0.21 | -0.37 | -0.21 | -0.33 |